QuiVad

Home / United Kingdom / Sartorius Stedim Biotech

Sartorius Stedim Biotech

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 2.33% on September 9, 2026. The shaded band is the year shown above.

November 3, 2023 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

Follow by RSS

Get the moves on Sartorius Stedim Biotech by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

33 disclosures on record for this share.
DateFund% of capitalEnd of publication
September 9, 2026Aggregated total2.33%September 14, 2026
September 3, 2026Aggregated total2.13%September 9, 2026
August 31, 2026Aggregated total1.93%September 3, 2026
August 18, 2026Aggregated total1.82%August 31, 2026
August 6, 2026Aggregated total1.72%August 18, 2026
July 27, 2026Aggregated total1.52%August 6, 2026
July 24, 2026Aggregated total1.72%July 27, 2026
July 13, 2026Aggregated total1.52%July 24, 2026
July 8, 2026Aggregated total0.81%July 13, 2026
May 19, 2026AQR Capital Management, LLC0.49%May 21, 2026
May 13, 2026AQR Capital Management, LLC0.50%May 21, 2026
July 18, 2025AQR Capital Management, LLC0.49%July 22, 2025
May 7, 2025AQR Capital Management, LLC0.50%July 22, 2025
January 24, 2025AQR Capital Management, LLC0.49%January 28, 2025
January 17, 2025AQR Capital Management, LLC0.50%January 28, 2025
December 6, 2024Qube Research & Technologies Limited0.01%December 10, 2024
December 5, 2024Qube Research & Technologies Limited0.50%December 10, 2024
December 4, 2024Qube Research & Technologies Limited0.49%December 6, 2024
December 3, 2024Qube Research & Technologies Limited0.50%December 6, 2024
November 29, 2024Qube Research & Technologies Limited0.49%December 3, 2024
November 28, 2024Qube Research & Technologies Limited0.50%December 3, 2024
November 27, 2024Qube Research & Technologies Limited0.49%November 29, 2024
November 20, 2024Qube Research & Technologies Limited0.50%November 29, 2024
October 29, 2024Qube Research & Technologies Limited0.49%October 31, 2024
September 19, 2024Qube Research & Technologies Limited0.50%October 31, 2024
September 16, 2024Qube Research & Technologies Limited0.49%September 18, 2024
August 23, 2024Qube Research & Technologies Limited0.50%September 18, 2024
August 22, 2024Qube Research & Technologies Limited0.49%August 26, 2024
August 16, 2024Qube Research & Technologies Limited0.50%August 26, 2024
July 12, 2024AQR Capital Management, LLC0.49%July 16, 2024
April 24, 2024AQR Capital Management, LLC0.50%July 16, 2024
November 16, 2023AQR Capital Management, LLC0.49%November 20, 2023
November 3, 2023AQR Capital Management, LLC0.50%November 20, 2023

Download 33 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United Kingdom

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Sartorius Stedim Biotech, source FCA, data as at September 9, 2026, https://www.quivad.com/action/sartorius-stedim-biotech